Endometriosis: new experience of non-hormonal treatment
OA: closed
CC0
⤵ 3 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper describes a new non-hormonal treatment experience for endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis 2009
- The Place of Gonadotropin-Releasing Hormone Agonists in the Management of Endometriosis 2014
Cited by (4)
- Modern view on the experimental creation of endometriosis in animal models (own data) 2024
- β-Adrenoreceptors types 1 and 2 in the diagnosis of pain syndrome in patientswith various forms of adenomyosis 2025
- FEATURES OF THE COURSE OF PREGNANCY, CHILDBIRTH AND POSTPARTUM PERIOD IN PATIENTS WITH ADENOMYOSIS 2020
- Activin A is a functional component of the anti-endometriotic drug Endoferin 2026
References (3)
Cited by (4)
- Activin A is a functional component of the anti-endometriotic drug Endoferin 2026
- β-Adrenoreceptors types 1 and 2 in the diagnosis of pain syndrome in patientswith various forms of adenomyosis 2025
- Modern view on the experimental creation of endometriosis in animal models (own data) 2024
- FEATURES OF THE COURSE OF PREGNANCY, CHILDBIRTH AND POSTPARTUM PERIOD IN PATIENTS WITH ADENOMYOSIS 2020
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-10-12T06:33:14.382917+00:00
License: CC0
· commercial use OK